Most Recent
Mylan fails in High Court bid to save patents for top seller Lipidil
The High Court has declined to take up Mylan's challenge to a Full Court ruling upholding the invalidity of three patents for its blockbuster cholesterol drug Lipidil.
Ex-Tennis Australia director Harold Mitchell must pay $90,000 in ASIC case
The Federal Court has ordered former Tennis Australia director Harold Mitchell to pay a $90,000 penalty after a "narrow" win for ASIC in its case over the domestic broadcast rights to the Australian Open.
Law firms behind competing AMP class actions fight consolidation
A showdown over two competing class actions against AMP is set down for December, and the applicants will have to persuade the judge overseeing the cases that they should not be consolidated.
Worley prevails in rare judgment dismissing shareholder class action
A judge has sided with Worley in a ruling tossing a class action after a trial alleged the engineering company misled shareholders and breached disclosure rules by issuing an overly positive earnings guidance of $322 million for the 2014 financial year.
Worley ruling the latest setback for shareholder class actions
A judge's decision to throw out a shareholder class action against engineering company Worley is a loss for plaintiffs lawyers and could result in fewer listed companies willing to settle cases alleging they breached their disclosure obligations, but the ruling is not likely to have a significant chilling effect on securities litigation.
AUSTRAC’s record $1.3B penalty for Westpac’s money laundering breaches wins court OK
A judge has given the greenlight to AUSTRAC's $1.3 billion penalty against Westpac over the bank's 23 million breaches of money laundering and counter-terrorism laws, the biggest regulatory fine ever paid by an Australian company.
Judge backs ASIC plan to ban OTC binary options as issuers hit with $75M penalty
Over-the-counter derivative issuers AGM Markets, OT Markets and Oxifin Tech have been ordered to pay a total of $75 million in penalties after a ruling that they engaged in unconscionable conduct causing losses of over $30 million to unsophisticated investors seeking what a judge called "financial heroin hits".
Full Court gives Branhaven another shot at bovine gene patent
Australia's leading livestock group cannot block US company Branhaven from amending its application for a bovine genome patent, which the group has worried could harm the Australian cattle industry's ability to use genetic tests.
‘The Ben Hur of cartel class actions’: Rate-rigging case comes under attack
Five investment banks facing a class action for their alleged rigging of foreign exchange rates have slammed the "unclear" and "incredibly vague" case, saying it contains "literally trillions" of possible variations of the cartel agreement allegedly entered into.